Shah Snehal, Barton Greg, Fischer Andreas
Department of Pharmacy, Royal Brompton and Harefield NHS Foundation Trust, London ,UK.
Department of Pharmacy, Whiston Hospital, St Helens and Knowsley Teaching Hospitals NHS Trust, Prescot, UK.
J Intensive Care Soc. 2015 May;16(2):147-153. doi: 10.1177/1751143714564816. Epub 2015 Jan 19.
The treatment of sepsis remains a significant challenge and is the cause of high mortality and morbidity. The pathophysiological alterations that are associated with sepsis can complicate drug dosing. Critical care patients often have capillary leak, increased cardiac output and altered protein levels which can have profound effects on the volume of distribution (Vd) and clearance (Cl) of antibacterial agents, both of which may affect the pharmacokinetics (PK) / pharmacodynamics (PD) of the drug. Along with antibacterial factors such as the hydrophilicity and its kill characteristics and the susceptibility and site of action of the microorganism, different dosing and administration strategies may be needed for the different drug classes. In conclusion, developing dosing and administration regimes of antibacterials that adhere to PK/PD principles increase antibacterial exposure. Tailoring therapy to the individual patient combined with TDM may contribute to improved clinical efficacy and contain the spread of resistance.
脓毒症的治疗仍然是一项重大挑战,也是导致高死亡率和高发病率的原因。与脓毒症相关的病理生理改变会使药物剂量确定变得复杂。重症监护患者常出现毛细血管渗漏、心输出量增加和蛋白质水平改变,这些都会对抗菌药物的分布容积(Vd)和清除率(Cl)产生深远影响,而这两者都可能影响药物的药代动力学(PK)/药效动力学(PD)。除了抗菌因素,如亲水性及其杀菌特性、微生物的敏感性和作用部位外,不同药物类别可能需要不同的给药剂量和给药策略。总之,制定符合PK/PD原则的抗菌药物给药方案可增加抗菌药物的暴露量。根据个体患者情况调整治疗方案并结合治疗药物监测(TDM)可能有助于提高临床疗效并遏制耐药性的传播。